Ra Capital Management reported a 15.9% stake in Inhibikase Therapeutics IKT · 25,000,000 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 15.9%
Last report: First report
Shares held: 25,000,000 sh
Class: Common Stock, $0.001 par value per share
Stock: Inhibikase Therapeutics IKT
Holder: Ra Capital Management
Event date: 26/07/10
Filed: 26/07/17

First 5%+ report · 15.9% stake

Inhibikase Therapeutics trades, last 26 weeks

What else happened in Inhibikase Therapeutics around then

Filed or reported within 30 days of the trade day · 06/10~08/09

Ra Capital Management's other 5% stake reports

Ra Capital Management
5% stakeCorbus Pharmaceuticals Holdings
5% stake
Corbus Pharmaceuticals Holdings
CRBP
9.9% stake
1,914,788 sh
9.9% stake
Filed 09/30
Ra Capital Management
5% stakeBetterLife Pharma
5% stake
BetterLife Pharma
BETRF
9% stake
55,420,000 sh
9% stake
Filed 09/22
Ra Capital Management
5% stakeSionna Therapeutics
5% stake
Sionna Therapeutics
SION
14.3% stake
6,476,193 sh
14.3% stake
Filed 09/21
Ra Capital Management
5% stakeTyra Biosciences
5% stake
Tyra Biosciences
TYRA
19.9% stake
14,130,492 sh
19.9% stake
Filed 09/17
Ra Capital Management
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.1% stake
450,000 sh
5.1% stake
Filed 09/03